Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Randall

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
British Journal of Pharmacology|April 19, 2005
The cardiovascular actions of anandamide: more targets?Michael D Randall
Molecular Pharmacology|February 28, 2003
A new endothelial target for cannabinoidsMichael D Randall
British Journal of Clinical Pharmacology|February 5, 2022
Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysisAdithan Ganesh, Michael D Randall
European Journal of Pharmacology|December 23, 2008
Effects of hypertension on vasorelaxation to endocannabinoids in vitroAmanda J Wheal, Michael D Randall
British Journal of Pharmacology|May 8, 2004
The complexities of the cardiovascular actions of cannabinoidsMichael D Randall, David A Kendall, Saoirse O'Sullivan
Vascular Pharmacology|April 15, 2015
Sex differences in the role of NADPH oxidases in endothelium-dependent vasorelaxation in porcine isolated coronary arteriesPui San Wong, Michael D Randall, Richard E Roberts
European Journal of Pharmacology|September 13, 2003
Mechanisms of vasorelaxation to 17beta-oestradiol in rat arteriesPatcharin Tep-areenan, David A Kendall, Michael D Randall
The Journal of Pharmacology and Experimental Therapeutics|February 8, 2007
The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthaseSaoirse E O'Sullivan, Michael D Randall, Sheila M Gardiner
European Journal of Pharmacology|April 26, 2012
Vasorelaxation to capsaicin and its effects on calcium influx in arteriesJamie J Hopps, William R Dunn, Michael D Randall
British Journal of Pharmacology|February 11, 2004
Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)Saoirse E O'Sullivan, David A Kendall, Michael D Randall
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Pharmacology|April 19, 2005
The cardiovascular actions of anandamide: more targets?Michael D Randall
Molecular Pharmacology|February 28, 2003
A new endothelial target for cannabinoidsMichael D Randall
British Journal of Clinical Pharmacology|February 5, 2022
Does metformin affect outcomes in COVID-19 patients with new or pre-existing diabetes mellitus? A systematic review and meta-analysisAdithan Ganesh, Michael D Randall
European Journal of Pharmacology|December 23, 2008
Effects of hypertension on vasorelaxation to endocannabinoids in vitroAmanda J Wheal, Michael D Randall
British Journal of Pharmacology|May 8, 2004
The complexities of the cardiovascular actions of cannabinoidsMichael D Randall, David A Kendall, Saoirse O'Sullivan
Vascular Pharmacology|April 15, 2015
Sex differences in the role of NADPH oxidases in endothelium-dependent vasorelaxation in porcine isolated coronary arteriesPui San Wong, Michael D Randall, Richard E Roberts
European Journal of Pharmacology|September 13, 2003
Mechanisms of vasorelaxation to 17beta-oestradiol in rat arteriesPatcharin Tep-areenan, David A Kendall, Michael D Randall
The Journal of Pharmacology and Experimental Therapeutics|February 8, 2007
The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthaseSaoirse E O'Sullivan, Michael D Randall, Sheila M Gardiner
European Journal of Pharmacology|April 26, 2012
Vasorelaxation to capsaicin and its effects on calcium influx in arteriesJamie J Hopps, William R Dunn, Michael D Randall
British Journal of Pharmacology|February 11, 2004
Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)Saoirse E O'Sullivan, David A Kendall, Michael D Randall
Pageof 4